We are live on
!
Find out more
BCTX
Briacell Therapeutics
BCTX
BCTX
16 hedge funds and large institutions have $1.62M invested in Briacell Therapeutics in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.01M | |
| 2 | +$344K | |
| 3 | +$303K | |
| 4 |
LCM
LuminArx Capital Management
New York
|
+$69.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$50.8K |
Top Sellers
| 1 | -$28.4K | |
| 2 | -$3.49K | |
| 3 | -$2.23K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$251 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$64 |
